Ateshkadi, Arasb, PharmD; Johnson, Curtis A., PharmD; Oxton, Lisa L., MT(ASCP); Hammond, Timothy G., MD; Bohenek, Wayne S., PharmD; Zimmerman, Stephen W., MD. Pharmacokinetics of Intraperitoneal, Intravenous, and Subcutaneous Recombinant Human Erythropoietin in Patients on Continuous Ambulatory Peritoneal Dialysis. American Journal of Kidney Diseases, vol. 21, No. 6, Jun., pp. 635-642, 1993. |
Breymann, Christian; Bauer, Christian; Major, Attila; Zimmerman, Roland; Gautschi, Kurt; Huch, Albert; Huch, Renate. Optimal timing of repeated rh-erythropoietin administration improves its effectiveness in stimulating erythropoiesis in healthy volunteers. British Journal of Haemotology, 92, 292-301, 1996. |
Egrie, J.C.; Strickland, T.W. Lane, J.; Aoki, K.; Cohen, A.M.; Smalling, R.; Trail, G., Lin, F.K.; Browne, J.K.; Hines, D.K. Characterization and Biological Effects of Recombinant Human Erythropoietin. Immunobiol. vol. 172, pp. 213-224 (1986). |
Faulds, Diana; Sorkin, Eugene M. Epoetin (Recombinant Human Erythropoietin) A Review of its Pharmacodynamic and Pharmacokinetic Properties and Therapeutic Potential in Anaemia and the Stimulation of Eryhropoiesis. Drugs 38 (6):863-899, 1989. |
Frenken, L.A.M., MD; van Lier, H.J.J., MSc; Jordans, J.G.M., MD, PhD; Leunissen, K.M.L., MD, PhD; van Leusen, R., MD, PhD; Verstappen, V.M.C., MD; Koene, R.A.P., MD, PhD. Identification of the Component Part in an Epoietin Alfa Preparation That Causes Pain After Subcutaneous Injection. American Journal of Kidney Diseases, vol. 22, No. 4, (Oct):pp 553-556, 1993. |
Granolleras, C.; Leskopf, W.; Shaldon, S.; Fourcade, J. Experience of pain after subcutaneous administration of different preparations of recombinant human erythropoietin: a randomized, double-blind crossover study. Clinical Nephrology, vol. 36, No. 6—(294-298), 1991. |
Halstenson, Charles E., PharmD; Macres, Mark, MS; Katz, Stephen A., PhD; Schneiders, James R., MS; Watanabe, Masakazu; Sobota, Joseph T., MD; Abraham, Paul A., MD. Comparative pharmacokinetics and pharmacodynamics of epoetin alfa and epoetin beta. Clin Pharmacol Ther, 50:702-12, 1991. |
Jacobs, Kenneth; Shoemaker, Charles; Rudersdorf, Richard; Neill, Suzanne D.; Kaufman, Randal J.; Mufson, Allan, Seehra, Jasbir; Jones, Simon S.; Hewick, Rodney; Fritsch, Edward F.; Kawakita, Makoto; Shimizu, Tomoe; Miyake, Takaji. Isolation and characterization of genomic and cDNA clones of human erythropoietin. Letters to Nature, vol. 313, Feb. 28, 1985. |
Jelkmann, Wolfgang. Erythropoietin: Structure, Control of Production, and Function. Physiological Reviews, vol. 72, No. 2, Apr., 1992. |
Koury, Stephen T.; Bondurant, Maurice C.; Koury, Mark J. Localization of Eryhropoietin Synthesizing Cells in Murine Kidneys By In Situ Hybridization. Concise Report, Blood, vol. 71, No. 2, (Feb.): pp 524-527, 1988. |
Lin, Fu-Kuen; Suggs, Sidney: Lin, Chi-Hwei; Browne, Jeffrey K.; Smalling, Ralph; Egrie, Joan C.; Chen, Kenneth K.; Fox, Gary M.; Martin, Frank; Stabinsky, Zippora; Badrawi, Sayed M.; Lai, Por-Hsiung; Goldwasser, Eugene. Cloning and expression of the human erythropoietin gene. Proc. Natl. Acad. Sci. USA, vol. 82, pp. 7580-7584, Nov. 1985. |
Markham, Anthony; Bryson, Harriet M. Epoetin Alfa, A Review of its Pharmacodynamic and Pharmacokinetic Properties and Therapeutic Use in Nonrenal Applications. Drugs 49 (2): 232-254, 1995. |
McMahon, Gilbert F.; Vargas, Ramon; Michael; Jain, Adesh K.; Abels, Robert I.; Perry, Barbara; Smith, Ian L. Pharmacokinetics and Effects of Recombinant Human Erythropoietin After Intravenous Subcutaneous Injections in Heathy Volunteers. Blood, vol 76, No. 9 (Nov. 1): pp 1718-1722, 1990. |
Salmonson, T.; Danielson, B.G,; Wikstrom, B. The pharmacokinetics of recombinant human erythropoeitin after intravenous and subcutaneous administration to healthy subjects. Br. J. clin. Pharmac., 29, 709-713, (1990). |